ZA201000107B - Pyrimidine derivatives 934 - Google Patents

Pyrimidine derivatives 934

Info

Publication number
ZA201000107B
ZA201000107B ZA201000107A ZA201000107A ZA201000107B ZA 201000107 B ZA201000107 B ZA 201000107B ZA 201000107 A ZA201000107 A ZA 201000107A ZA 201000107 A ZA201000107 A ZA 201000107A ZA 201000107 B ZA201000107 B ZA 201000107B
Authority
ZA
South Africa
Prior art keywords
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Application number
ZA201000107A
Other languages
English (en)
Inventor
Bernard Christophe Barlaam
Richard Ducray
Jason Grant Kettle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA201000107B publication Critical patent/ZA201000107B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA201000107A 2007-07-16 2010-01-06 Pyrimidine derivatives 934 ZA201000107B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07301236 2007-07-16

Publications (1)

Publication Number Publication Date
ZA201000107B true ZA201000107B (en) 2010-09-29

Family

ID=40260140

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201000107A ZA201000107B (en) 2007-07-16 2010-01-06 Pyrimidine derivatives 934

Country Status (18)

Country Link
US (1) US7718653B2 (de)
EP (1) EP2183242A2 (de)
JP (1) JP2010533700A (de)
KR (1) KR20100042272A (de)
CN (1) CN101796046A (de)
AU (1) AU2008277446A1 (de)
BR (1) BRPI0814821A2 (de)
CA (1) CA2693880A1 (de)
CO (1) CO6260075A2 (de)
CR (1) CR11220A (de)
DO (1) DOP2010000022A (de)
EA (1) EA201000101A1 (de)
EC (1) ECSP109958A (de)
MX (1) MX2010000658A (de)
NI (1) NI201000011A (de)
SV (1) SV2010003459A (de)
WO (1) WO2009010789A2 (de)
ZA (1) ZA201000107B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8927547B2 (en) 2010-05-21 2015-01-06 Noviga Research Ab Pyrimidine derivatives
DK2688883T3 (en) 2011-03-24 2016-09-05 Noviga Res Ab pyrimidine
SMT202400031T1 (it) 2011-04-22 2024-03-13 Signal Pharm Llc Diamminocarbossammide e diamminocarbonitrile pirimidine sostituite, loro composizioni e metodi di trattamento con esse
JP5931178B2 (ja) 2011-05-03 2016-06-08 フェニックス コンタクト ゲーエムベーハー ウント コムパニー カーゲー 電磁誘導による非接触電力伝送のための構成
CN103222842B (zh) 2013-04-18 2015-09-09 安翰光电技术（武汉）有限公司 一种控制胶囊内窥镜在人体消化道运动的装置及方法
NZ715903A (en) 2014-01-30 2017-06-30 Signal Pharm Llc Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
BR112017012795A2 (pt) 2014-12-16 2018-01-02 Signal Pharmaceuticals, Llc Formulações de 2-(terc-butilamino)-4-((1r,3r,4r)-3- hidroxi-4-metilciclo-hexilamino)-pirimidina-5- carboxamida
EP3233808B1 (de) 2014-12-16 2021-07-14 Signal Pharmaceuticals, LLC Medizinische verwendungen, die verfahren zur messung der hemmung der c-jun-n-terminalen kinase in der haut beinhalten
WO2016123291A1 (en) 2015-01-29 2016-08-04 Signal Pharmaceuticals, Llc Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
CA3208587A1 (en) 2015-07-24 2017-02-02 Celgene Corporation Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
CN106543089A (zh) * 2016-11-04 2017-03-29 山东铂源药业有限公司 一种达沙替尼中间体的合成方法
JP2023527242A (ja) * 2020-05-29 2023-06-27 南京正大天晴制薬有限公司 Ａｘｌ阻害剤であるピリミジン系化合物
CN116178433A (zh) * 2021-11-26 2023-05-30 南京正大天晴制药有限公司 Axl激酶抑制剂的盐及其制备方法和用途
CN116178434A (zh) * 2021-11-26 2023-05-30 南京正大天晴制药有限公司 Axl激酶抑制剂的单对甲苯磺酸盐及其晶型

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1257546A1 (de) * 2000-02-17 2002-11-20 Amgen Inc. Kinase inhibitoren
ES2286408T3 (es) 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
NZ585188A (en) * 2003-08-15 2011-09-30 Novartis Ag 2,4-Pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
US7521457B2 (en) * 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
GB0419161D0 (en) * 2004-08-27 2004-09-29 Novartis Ag Organic compounds
US20060247250A1 (en) 2005-03-16 2006-11-02 Targegen, Inc. Pyrimidine inhibitors of kinases
WO2006129100A1 (en) * 2005-06-03 2006-12-07 Glaxo Group Limited Novel compounds
AR054834A1 (es) 2005-07-15 2007-07-18 Glaxo Group Ltd Derivados de 1,1-dioxido-2,3-dihidro-1,2-benzoisotiazol-6-il-1h-indazol-4-il-2,4 pirimidina diamina
WO2007028445A1 (en) * 2005-07-15 2007-03-15 Glaxo Group Limited 6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
US20090149467A1 (en) 2005-09-15 2009-06-11 Merck & Co., Inc. Tyrosine Kinase Inhibitors
CN103626742B (zh) * 2005-11-01 2017-04-26 塔格根公司 激酶的联-芳基间-嘧啶抑制剂
TW200736232A (en) 2006-01-26 2007-10-01 Astrazeneca Ab Pyrimidine derivatives
WO2007085540A1 (en) 2006-01-27 2007-08-02 Glaxo Group Limited 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
TW200840581A (en) * 2007-02-28 2008-10-16 Astrazeneca Ab Novel pyrimidine derivatives
US7947698B2 (en) * 2007-03-23 2011-05-24 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
WO2008132505A1 (en) 2007-04-27 2008-11-06 Astrazeneca Ab N' - (phenyl) -n- (morpholin-4-yl-pyridin-2-yl) -pyrimidine-2, 4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions

Also Published As

Publication number Publication date
CR11220A (es) 2010-05-20
DOP2010000022A (es) 2010-02-15
CN101796046A (zh) 2010-08-04
WO2009010789A3 (en) 2009-05-07
ECSP109958A (es) 2010-03-31
CO6260075A2 (es) 2011-03-22
JP2010533700A (ja) 2010-10-28
NI201000011A (es) 2010-12-07
SV2010003459A (es) 2010-04-30
AU2008277446A1 (en) 2009-01-22
BRPI0814821A2 (pt) 2015-02-03
EA201000101A1 (ru) 2010-08-30
MX2010000658A (es) 2010-03-26
WO2009010789A2 (en) 2009-01-22
CA2693880A1 (en) 2009-01-22
US20090023719A1 (en) 2009-01-22
US7718653B2 (en) 2010-05-18
EP2183242A2 (de) 2010-05-12
KR20100042272A (ko) 2010-04-23

Similar Documents

Publication Publication Date Title
IL205425A0 (en) Novel pyrimidine derivatives
IL192610A0 (en) Pyrimidine derivatives
HRP20140377T1 (en) Pyrimidine derivatives
GB0713259D0 (en) Pyrazine derivatives 954
ZA200805294B (en) Pyrimidine derivatives
ZA201000107B (en) Pyrimidine derivatives 934
IL205759A0 (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
IL202020A0 (en) Spiroindolinone derivatives
GB0614579D0 (en) Pyrimidine derivatives
ZA201001058B (en) Quinazolinamide derivatives
ZA201000431B (en) Indazolamide derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
GB0525080D0 (en) Pyrimidine derivatives
GB0525083D0 (en) Pyrimidine derivatives
IL202667A0 (en) Isoxazole-imidazole derivatives
EP2094704A4 (de) Cis-cyclohexyl-substituierte pyrimidinon-derivate
PL2245028T3 (pl) Pochodne 5-aminocyklilometyloksazolidyn-2-onu
GB0525081D0 (en) Pyrimidine derivatives
EP2133347A4 (de) 1-biarylazetidinonderivate
IL202463A0 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
ZA201002218B (en) Thiadiazinone derivatives
HK1143146A (en) Pyrimidine derivatives 934